Related Experiment Videos
Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines
P Strippoli1, G P Bagnara, L Montanaro
1Institute of Histology, University of Bologna, Bologna, Italy.
Anticancer Research
|February 24, 2001
Summary
Retinoic acid (RA) increases stem cell factor (SCF) production in neuroblastoma (NB) cells. This finding suggests RA may play a role in neuroblastoma development and offers potential therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Stem cell factor (SCF) and its receptor c-kit are implicated in certain cancers, including neuroblastoma (NB).
- Retinoic acid (RA) is a known differentiating agent for human NB cells.
Purpose of the Study:
- To investigate the effect of retinoic acid (RA) on stem cell factor (SCF) production in human neuroblastoma (NB) cell lines.
- To determine if RA influences SCF mRNA expression in NB cells.
Main Methods:
- Immunoenzymatic assay was used to quantify SCF concentrations in cell supernatants.
- Reverse-transcription polymerase chain reaction (RT-PCR) detected membrane SCF mRNA isoforms.
- Seven human neuroblastoma cell lines were cultured and treated with RA.
Main Results:
- All tested NB cell lines, except one, secreted detectable SCF levels under basal conditions.
- RA treatment significantly increased SCF concentrations in NB cell supernatants after 48 and 72 hours compared to controls (p < 0.01).
- SCF mRNA was detected in the cell membranes, indicating active production.
Conclusions:
- Retinoic acid (RA) enhances stem cell factor (SCF) production in neuroblastoma (NB) cell lines.
- RA's dual action of inducing neuronal differentiation and increasing SCF production highlights its complex role in NB.
- These findings suggest potential therapeutic strategies targeting the SCF pathway in neuroblastoma.